Palmoplantar Psoriasis

Mild-to-Moderate: Psoriasis

Volumn , Issue , 2006, Pages 183-194

  Bonish, Brian ^a   Kenneth B Gordon, ^b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052983305     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b14276-18     Document Type: Chapter

References (33)

1. Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003; 49(2):271-275.
2. Kumar B, Saraswat A, Kaur I. Palmoplantar lesions in psoriasis: a study of 3065 patients. Acta Derm Venereol 2002; 82(3):192-195.
3. Fransson J, Storgards K, Hammar H. Palmoplantar lesions in psoriatic patients and their relation to inverse psoriasis, tinea infection and contact allergy. Acta Derm Venereol 1985; 64:218-223.
4. Eriksson MO, Hagforsen E, Lundin IP, Michaelsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 1998; 138(3):390-398.
5. Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 2003; 120(4):627-632.
6. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol 1992; 72(1):69-71.
7. Thiers BH. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol 1997; 37(3 Pt 2):S69-S71; 5.
8. Duweb GA, Abuzariba O, Rahim M, al Taweel M, al Alem S, Abdulla SA. Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis. Int J Tissue React 2001; 23(2):59-62; 3.
9. Spuls PI, Hadi S, Rivera L, Lebwohl M. Retrospective analysis of the treatment of psoriasis of the palms and soles. J Dermatol Treat 2003; 14(suppl 2):21-25.
10. Lewis A, Nigro M, Rosen T. Treatment of keratoderma blennorrhagicum with tazarotene gel 0.1%. J Am Acad Dermatol 2000; 43(2 Pt 2):400-402.
11. Kumar B, Sandhu K, Kaur I. Topical 0.25% methotrexate gel in a hydrogel base for palmoplantar psoriasis. J Dermatol 2004; 31(10):798-801.
12. Nordal EJ, Christensen OB. Treatment of chronic hand dermatoses with UVBTL01. Acta Derm Venereol 2004; 84(4):302-304.
13. Agren-Jonsson S, Tegner E. PUVA therapy for palmoplantar pustulosis. Acta Derm Venereol 1985; 65(6):531-535.
14. Behrens S, von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 1999; 15(2):47-51.
15. Davis MD, McEvoy MT, el Azhary RA. Topical psoralen-ultraviolet A therapy for palmoplantar dermatoses: experience with 35 consecutive patients. Mayo Clin Proc 1998; 73(5):407-411.
16. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999; 15(2):87-89.
17. Hawk JL, Grice PL. The efficacy of localized PUVA therapy for chronic hand and foot dermatoses. Clin Exp Dermatol 1994; 19(6):479-482.
18. Layton AM, Sheehan-Dare R, Cunliffe WJ. A double-blind, placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 1991; 124(6):581-584.
19. Schiener R, Gottlober P, Muller B, et al. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study. Photodermatol Photoimmunol Photomed 2005; 21(2):62-67.
20. Taylor CR, Baron ED. Hand and foot PUVA soaks: an audit of the Massachusetts General Hospital’s experience from 1994 to 1998. Photodermatol Photoimmunol Photomed 1999; 15(5):188-192.
21. Aubin F, Vigan M, Puzenat E, et al. Evaluation of a novel 308-nm monochromatic excimer light delivery system in dermatology: a pilot study in different chronic localized dermatoses. Br J Dermatol 2005; 152(1):99-103.
22. Thune P. Treatment of palmoplantar pustulosis with Tigason. Dermatologica 1982; 164(1):67-72.
23. White SI, Marks JM, Shuster S. Etretinate in pustular psoriasis of palms and soles. Br J Dermatol 1985; 113(5):581-585.
24. White SI, Puttick L, Marks JM. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. Br J Dermatol 1986; 115(5):577-582.
25. Rosen K, Mobacken H, Swanbeck G. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial. Arch Dermatol 1987; 123(7):885-889.
26. Lassus A, Lauharanta J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol 1985; 112(4):455-459.
27. Lawrence CM, Marks J, Parker S, Shuster S. A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis. Br J Dermatol 1984; 110(2):221-226.
28. Reitamo S, Erkko P, Remitz A, Lauerma AI, Montonen O, Harjula K. Cyclosporine in the treatment of palmoplantar pustulosis. A randomized, double-blind, placebo-controlled study. Arch Dermatol 1993; 129(10):1273-1279.
29. Meinardi MM, de Rie MA, Bos JD. Oral cyclosporin A is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol 1990; 70(1):77-79.
30. Meinardi MM, de Rie MA, Bos JD. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands. Br J Dermatol 1990; 122(suppl 36):27-31.
31. Myers W, Christiansen L, Gottlieb AB. Treatment of palmoplantar psoriasis with intramuscular alefacept. J Am Acad Dermatol 2005; 53(suppl 2):S127-S129.
32. Weinberg JM. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept. Cutis 72(5):396-398.
33. Mease PJ. Recent advances in the management of psoriatic arthritis. Curr Opin Rheumatol 2004; 16(4):366-370.